Surgical Considerations

• Minimum implant distance: 3 mm
• Mesio – distal space for 2 implants: 14 mm
• Twist drill speed: 800 – 1500 rpm (2mm drill)
• Piezosurgery: Invented by Vercellotti, developed by Mectron

Biological Considerations

• Peri – implant biological width: 4 – 4.5 mm (epithelial attachment + supracrestal CT)
• Maximum bone loss: First 6 – 24 months post – extraction

• Bence Jones Proteins: Mostly gamma chains
• Commonest lytic lesion site: Vertebral column
• Russell bodies: Found in plasma cells
• Bone scan not useful
• No ALP elevation
• High ESR: Often seen
• Prognostic marker: Beta-2 microglobulin

🔁 Pulse Patterns

🔊 Heart Sounds

• Loud S1: Short PR interval, tachycardia, mitral stenosis
• Fourth Heart Sound (S4): Heard during ventricular filling
• Opening snap: High-pitched, diastolic sound

• Normal count + ↑ BT: Platelet functional defect
• Small platelets: Wiskott – Aldrich syndrome
• ITP: Antibody against platelets, ↑ bleeding time
• Platelet transfusion not indicated in immunologic thrombocytopenia
• Thrombocytopenia not seen in Henoch – Schönlein purpura

Periodontal Bone Grafts

Bone grafting is a critical procedure in periodontal surgery, aimed at restoring lost bone and supporting the regeneration of periodontal tissues.

1. Bone Blend

 Bone blend is a mixture of cortical or cancellous bone that is procured using a trephine or rongeurs, placed in an amalgam capsule, and triturated to achieve a slushy osseous mass. This technique allows for the creation of smaller particle sizes, which enhances resorption and replacement with host bone.

Particle Size: The ideal particle size for bone blend is approximately 210 x 105 micrometers.

Rationale: Smaller particle sizes improve the chances of resorption and integration with the host bone, making the graft more effective.

2. Types of Periodontal Bone Grafts

A. Autogenous Grafts

Autogenous grafts are harvested from the patient’s own body, providing the best compatibility and healing potential.

1. Cortical Bone Chips

   • History: First used by Nabers and O'Leary in 1965.
   • Characteristics: Composed of shavings of cortical bone removed during osteoplasty and ostectomy from intraoral sites.
   • Challenges: Larger particle sizes can complicate placement and handling, and there is a potential for sequestration. This method has largely been replaced by autogenous osseous coagulum and bone blend.

2. Osseous Coagulum and Bone Blend

   • Technique: Intraoral bone is obtained using high- or low-speed round burs and mixed with blood to form an osseous coagulum (Robinson, 1969).
   • Advantages: Overcomes disadvantages of cortical bone chips, such as inability to aspirate during collection and variability in quality and quantity of collected bone.
   • Applications: Used in various periodontal procedures to enhance healing and regeneration.

3. Intraoral Cancellous Bone and Marrow

   • Sources: Healing bony wounds, extraction sockets, edentulous ridges, mandibular retromolar areas, and maxillary tuberosity.
   • Applications: Provides a rich source of osteogenic cells and growth factors for bone regeneration.

4. Extraoral Cancellous Bone and Marrow

   • Sources: Obtained from the anterior or posterior iliac crest.
   • Advantages: Generally offers the greatest potential for new bone growth due to the abundance of cancellous bone and marrow.

B. Bone Allografts

Bone allografts are harvested from donors and can be classified into three main types:

1. Undermineralized Freeze-Dried Bone Allograft (FDBA)

   • Introduction: Introduced in 1976 by Mellonig et al.
   • Process: Freeze drying removes approximately 95% of the water from bone, preserving morphology, solubility, and chemical integrity while reducing antigenicity.
   • Efficacy: FDBA combined with autogenous bone is more effective than FDBA alone, particularly in treating furcation involvements.

2. Demineralized (Decalcified) FDBA

   • Mechanism: Demineralization enhances osteogenic potential by exposing bone morphogenetic proteins (BMPs) in the bone matrix.
   • Osteoinduction vs. Osteoconduction: Demineralized grafts induce new bone formation (osteoinduction), while undermineralized allografts facilitate bone growth by providing a scaffold (osteoconduction).

3. Frozen Iliac Cancellous Bone and Marrow

   • Usage: Used sparingly due to variability in outcomes and potential complications.

Comparison of Allografts and Alloplasts

• Clinical Outcomes: Both FDBA and DFDBA have been compared to porous particulate hydroxyapatite, showing little difference in post-treatment clinical parameters.
• Histological Healing: Grafts of DFDBA typically heal with regeneration of the periodontium, while synthetic bone grafts (alloplasts) heal by repair, which may not restore the original periodontal architecture.

Platelet-Derived Growth Factor (PDGF)

Platelet-Derived Growth Factor (PDGF) is a crucial glycoprotein involved in various biological processes, particularly in wound healing and tissue repair. Understanding its role and mechanisms can provide insights into its applications in regenerative medicine and periodontal therapy.

Overview of PDGF

1. Definition:

   • PDGF is a glycoprotein that plays a significant role in cell growth, proliferation, and differentiation.

2. Source:

   • PDGF is carried in the alpha granules of platelets and is released during the process of blood clotting.

3. Discovery:

   • It was one of the first growth factors to be described in scientific literature.
   • Originally isolated from platelets, PDGF was found to exhibit mitogenic activity specifically in smooth muscle cells.

Functions of PDGF

1. Mitogenic Activity:

   • PDGF stimulates the proliferation of various cell types, including:
     • Smooth muscle cells
     • Fibroblasts
     • Endothelial cells
   • This mitogenic activity is essential for tissue repair and regeneration.

2. Role in Wound Healing:

   • PDGF is released at the site of injury and plays a critical role in:
     • Promoting cell migration to the wound site.
     • Stimulating the formation of new blood vessels (angiogenesis).
     • Enhancing the synthesis of extracellular matrix components, which are vital for tissue structure and integrity.

3. Involvement in Periodontal Healing:

   • In periodontal therapy, PDGF can be utilized to enhance healing in periodontal defects and promote regeneration of periodontal tissues.
   • It has been studied for its potential in guided tissue regeneration (GTR) and in the treatment of periodontal disease.

Clinical Applications

1. Regenerative Medicine:

   • PDGF is being explored in various regenerative medicine applications, including:
     • Bone regeneration
     • Soft tissue healing
     • Treatment of chronic wounds

2. Periodontal Therapy:

   • PDGF has been incorporated into certain periodontal treatment modalities to enhance healing and regeneration of periodontal tissues.
   • It can be used in conjunction with graft materials to improve outcomes in periodontal surgery.